Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective α1-adrenoceptor antagonist that binds to α1A and α1D receptors in the prostate, bladder neck, and urethra. It acts to relax smooth muscle, thereby reducing urinary symptoms.
## Primary Indications
* Signs and symptoms of benign prostatic hyperplasia (BPH).
* Off-label: Medical expulsive therapy (MET) for distal ureteral stones.
## Adult Dosing
* **BPH:** 0.4 mg orally once daily, taken 30 minutes after the same meal each day.
* **Maximum Dose:** 0.8 mg daily if the 0.4 mg dose is well-tolerated but ineffective after 2–4 weeks.
## Pediatric Dosing
* **Safety/Efficacy:** Not established for pediatric patients. Tamsulosin is generally not indicated for pediatric use.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment indicated for mild-to-moderate impairment. Use with caution in severe renal impairment (CrCl <10 mL/min).
* **Hepatic Impairment:** No dosage adjustment needed for mild-to-moderate impairment; not studied in severe hepatic impairment.
* **CYP3A4/2D6 Inhibitors:** Use with caution when co-administered with strong inhibitors (e.g., ketoconazole, paroxetine).
## Contraindications
* Known hypersensitivity (e.g., serious skin reactions, angioedema) to tamsulosin.
* Concomitant use of strong CYP3A4 inhibitors (if on 0.8 mg dose).
## Adverse Effects
* **Common:** Orthostatic hypotension, dizziness, headache, abnormal ejaculation (retrograde), rhinitis, and asthenia.
* **Serious:** Intraoperative Floppy Iris Syndrome (IFIS) during cataract/glaucoma surgery, syncope, priapism (rare).
## Key Drug Interactions
* **PDE-5 Inhibitors:** Increased risk of symptomatic hypotension. Should be initiated only after stable alpha-blocker therapy is established.
* **Antihypertensives:** Potential additive hypotensive effects.
* **CYP3A4 Inhibitors:** May significantly increase plasma concentrations of tamsulosin.
## Monitoring
* Monitor blood pressure periodically, especially upon initiation or dose escalation.
* Assess symptom improvement via International Prostate Symptom Score (IPSS).
* Screen for prostate cancer prior to initiating therapy to rule out malignancy.
## Clinical Pearls
* **Administration:** Must be taken 30 minutes after the same meal every day to ensure consistent bioavailability. Crushing or chewing the capsule destroys the sustained-release mechanism.
* **Surgical Warning:** Patients should inform their ophthalmologist of current or past tamsulosin use before cataract or glaucoma surgery due to the high risk of IFIS.
* **Initial Dose:** First-dose effect (dizziness/fainting) is less common with tamsulosin compared to non-selective alpha-blockers like terazosin, but remains a risk.
***
**Educational Disclaimer:** This information is for educational purposes only. Always verify dosages, contraindications, and drug interactions with the most current clinical resources (e.g., Lexicomp, UpToDate) or local institutional protocols before prescribing or administering medication.
